Posted in M&A / Deals Symeres and Ambagon collaborate for colorectal cancer molecules April 1, 2026 Pharmaceutical Business Review The partnership aims to explore a new class of small molecules, called molecular glues, which enable or stabilise interactions between proteins. M&A / DealsOncologyRead full story